Updated Jul 16, 2026
Chung Lauren is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Lauren Chung serves as a director of Profusa, Inc., a clinical-stage digital health and medical technology company focused on biosensing solutions. This designation is listed in Profusa's SEC filing dated January 29, 2026. The filing indicates no stock purchases or sales by her in connection with the company.
| Role | Director |
|---|---|
| Notability | 52/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-01-30 | PFSA | Profusa, Inc. | J — Other acquisition / disposition | 30.0K | — |
Lauren Chung serves as a director of Profusa, Inc., a clinical-stage digital health and medical technology company focused on biosensing solutions. This designation is listed in Profusa's SEC filing dated January 29, 2026. The filing indicates no stock purchases or sales by her in connection with the company.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Chung Lauren profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.